InsidersTradesSigma
Track the Transcode Therapeutics, Inc. share price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Operating in the Health Care sector, Transcode Therapeutics, Inc. has recorded 10 reports. Market capitalisation: €8m. The latest transaction was filed on 5 August 2026 (C). Among the most active insiders: Dudley Robert Michael. All data is free.
10
Insider Decl.
n/a
Thresholds
€269,443
8 ops.
Buy Volume
n/a
n/a
Sell Volume
58Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 5 August 2026
Declarations10 total
98,000 shares@ US$0.5120.5% of flowCommon StockSEC:0001104659-23-105924:0
Canonical exit: 27 Dec 2023 (T+90)
49,350 shares@ US$0.5162.3% of flowCommon StockSEC:0001104659-23-105925:0
Canonical exit: 27 Dec 2023 (T+90)
6,607 shares@ US$2.54986.7% of flowCommon StockSEC:0001104659-23-073872:0
Canonical exit: 18 Sept 2023 (T+90)
19,000 shares@ US$2.7621.0% of flowCommon StockSEC:0001104659-23-071204:0
Canonical exit: 7 Sept 2023 (T+90)
19,000 shares@ US$2.7621.0% of flowCommon StockSEC:0001104659-23-070804:0
Canonical exit: 7 Sept 2023 (T+90)
20,000 shares@ US$1.1510.0% of flowCommon StockSEC:0001104659-22-100931:0
Canonical exit: 13 Dec 2022 (T+90)
12,000 shares@ US$1.270.24% mcap100.0% of flowCommon StockSEC:0001104659-22-072369:0
Canonical exit: 14 Sept 2022 (T+90)
28,000 shares@ US$1.84440.80% mcap100.0% of flowCommon StockSEC:0001104659-22-067099:0
Canonical exit: 25 Aug 2022 (T+90)
10 of 10 declarations
Acerca de Transcode Therapeutics, Inc.
Transcode Therapeutics, Inc. es una empresa centrada en el desarrollo de terapias innovadoras para el tratamiento del cáncer. Se especializa en soluciones basadas en ARN para mejorar los resultados de los pacientes.